| __timestamp | Alpine Immune Sciences, Inc. | argenx SE |
|---|---|---|
| Wednesday, January 1, 2014 | 2287709 | 4241601.57 |
| Thursday, January 1, 2015 | 6844000 | 5392385.38 |
| Friday, January 1, 2016 | 8586000 | 7370036.73 |
| Sunday, January 1, 2017 | 6079000 | 14970357 |
| Monday, January 1, 2018 | 8362000 | 31413266 |
| Tuesday, January 1, 2019 | 9467000 | 72279461 |
| Wednesday, January 1, 2020 | 10899000 | 183907682 |
| Friday, January 1, 2021 | 14560000 | 307644000 |
| Saturday, January 1, 2022 | 17968000 | 472132000 |
| Sunday, January 1, 2023 | 22222000 | 709539000 |
Unleashing the power of data
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Argenx SE and Alpine Immune Sciences, Inc. offer a fascinating case study in this regard. Over the past decade, Argenx SE has seen its SG&A expenses skyrocket by over 16,000%, from approximately $4.2 million in 2014 to a staggering $709 million in 2023. In contrast, Alpine Immune Sciences, Inc. has maintained a more modest increase of around 872%, from $2.3 million to $22 million over the same period.
This dramatic difference highlights Argenx SE's aggressive expansion strategy, while Alpine Immune Sciences, Inc. appears to focus on more controlled growth. Investors and industry analysts should consider these trends when evaluating the operational efficiency and strategic direction of these companies.
Operational Costs Compared: SG&A Analysis of Zoetis Inc. and argenx SE
Operational Costs Compared: SG&A Analysis of argenx SE and CRISPR Therapeutics AG
Who Optimizes SG&A Costs Better? argenx SE or Bausch Health Companies Inc.
Cost Management Insights: SG&A Expenses for argenx SE and ACADIA Pharmaceuticals Inc.
Breaking Down SG&A Expenses: Dr. Reddy's Laboratories Limited vs Alpine Immune Sciences, Inc.
SG&A Efficiency Analysis: Comparing Exelixis, Inc. and Alpine Immune Sciences, Inc.
SG&A Efficiency Analysis: Comparing Alpine Immune Sciences, Inc. and Ultragenyx Pharmaceutical Inc.
Alpine Immune Sciences, Inc. or CymaBay Therapeutics, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Alpine Immune Sciences, Inc. vs Vericel Corporation
Selling, General, and Administrative Costs: Alpine Immune Sciences, Inc. vs Supernus Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and Galapagos NV
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and BioCryst Pharmaceuticals, Inc.